Preparation and functional characterization of tumor-targeted folic acid-chitosan conjugated nanoparticles loaded with mitoxantrone

被引:22
作者
Wang Wei [1 ]
Tong Chun-yi [2 ]
Liu Xing-yan [1 ]
Li Tao [1 ]
Liu Bin [2 ]
Xiong Wei [3 ]
机构
[1] Guangdong Med Coll, Dongguan Res Ctr, Dongguan 523808, Peoples R China
[2] Hunan Univ, Coll Biol, Changsha 410082, Hunan, Peoples R China
[3] Cent S Univ, Xiangya Hosp 2, Dept Ophthalmol, Changsha 410011, Hunan, Peoples R China
基金
中国国家自然科学基金;
关键词
folic acid; chitosan; nanoparticles; mitoxantrone; tumor targeting; DRUG-DELIVERY; GENE DELIVERY; CANCER; MICROSPHERES; 5-FLUOROURACIL; RELEASE; LIGAND;
D O I
10.1007/s11771-015-2871-5
中图分类号
TF [冶金工业];
学科分类号
0806 ;
摘要
Folic acid conjugated chitosan was prepared by cross-linking reaction with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), and then used as a template to prepare folic acid-chitosan (FA-CS) conjugated nanoparticles and load mitoxantrone nanoparticles (FA-CSNP/MTX). Drug dissolution testing, CCK-8 method, and confocal microscopy were used to detect their controlled-release capability in different situations and the specific uptake by HONE1 cells. The experimental results show that the nanoparticles have uniform size distribution of 48-58 nm. The highest encapsulation rate of the particles on mitoxantrone hydrochloride (MTX) is (77.5 +/- 1.9)%, and the drug loading efficiency is (18.4 +/- 0.4)%. The sustained release effect, cell growth inhibition activity and targeting effect of the FA-CS/MTX nanoparticles are good in artificial gastric fluid and intestinal fluid. It is demonstrated that the FA-CSNP system is a potentially useful system for the targeted delivery of anticancer drug MTX.
引用
收藏
页码:3311 / 3317
页数:7
相关论文
共 28 条
  • [1] A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse
    Advani, Anjali S.
    Shadman, Mazyar
    Ali-Osman, Francis
    Barker, Andrew
    Rybicki, Lisa
    Kalaycio, Matt
    Sekeres, Mikkael A.
    de Castro, Carlos M.
    Diehl, Louis F.
    Moore, Joseph O.
    Beaven, Anne
    Copelan, Ed
    Sobecks, Ronald
    Talea, Parisa
    Rizzieri, David A.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (06) : 473 - 476
  • [2] Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
    Alpar, HO
    Somavarapu, S
    Atuah, KN
    Bramwell, V
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (03) : 411 - 430
  • [3] Chitosan-based delivery systems for protein therapeutics and antigens
    Amidi, Maryam
    Mastrobattista, Enrico
    Jiskoot, Wim
    Hennink, Wim E.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) : 59 - 82
  • [4] Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur
    Arias, Jose L.
    Lopez-Viota, Margarita
    Gallardo, Visitacion
    Adolfina Ruiz, Maria
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2010, 36 (06) : 744 - 750
  • [5] Chitosan-based hydrogels for controlled, localized drug delivery
    Bhattarai, Narayan
    Gunn, Jonathan
    Zhang, Miqin
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2010, 62 (01) : 83 - 99
  • [6] Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles
    Chakravarthi, Sudhir S.
    Robinson, Dennis H.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2011, 409 (1-2) : 111 - 120
  • [7] Self-Reporting Liposomes for Intracellular Drug Release
    Chen, Wansong
    Huang, Qiyu
    Ou, Weizhu
    Hao, Yuanqiang
    Wang, Liqiang
    Zeng, Ke
    Guo, Hongyan
    Li, Juan
    Liu, You-Nian
    [J]. SMALL, 2014, 10 (07) : 1261 - 1265
  • [8] Denkbas EB, 1999, J MICROENCAPSUL, V16, P741
  • [9] Diah SK, 2001, CANCER RES, V61, P5461
  • [10] Receptor-mediated gene delivery by folic acid-modified stearic acid-grafted chitosan micelles
    Du, Yong-Zhong
    Cai, Li-Li
    Li, Jin
    Zhao, Meng-Dan
    Chen, Feng-Ying
    Yuan, Hong
    Hu, Fu-Qiang
    [J]. INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 : 1559 - 1568